Director Deborah Taylor Tate filed a Form 4 with the SEC on November 6, 2026, reporting the sale of 3,281 shares of HealthStream Inc. common stock on November 5, 2026.

Key Highlights

  • Reporting person: Deborah Taylor Tate, identified as a Director of HealthStream Inc. (NASDAQ:HSTM)
  • Transaction: Sale (transaction code S) of 3,281 shares of common stock on November 5, 2026
  • Weighted average price: $32.192 per share, with individual trades ranging from $32.05 to $32.40
  • Remaining holdings: 21,418 shares of common stock held directly following the transaction
  • Multiple trades: The filing notes the transaction was executed across multiple trades at varying prices within the stated range

HealthStream Director Reports Common Stock Sale on November 5, 2026

According to the Form 4 filed on November 6, 2026, Deborah Taylor Tate, a director of HealthStream Inc. (NASDAQ:HSTM), disposed of 3,281 shares of the company's common stock. The transaction date is listed as November 5, 2026, and the filing covers a direct ownership position with no indirect or derivative securities reported.

The filing discloses that the sale was executed across multiple trades. The price reported, $32.192, reflects a weighted average sale price. According to footnote 1 in the filing, "The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected." Individual trade prices ranged from $32.05 to $32.40, as stated in the filing.

Following the reported transaction, Tate's direct beneficial ownership in HealthStream Inc. common stock stands at 21,418 shares, according to the filing. No derivative securities were reported in Table II. The Form 4 was filed by one reporting person and is not indicated as an amendment to a prior filing.

What Was Disclosed

Director Deborah Taylor Tate reported the sale of 3,281 shares of HealthStream Inc. common stock on November 5, 2026, at a weighted average price of $32.192, leaving her with 21,418 directly held shares, according to the Form 4 filed November 6, 2026.